Rchr
J-GLOBAL ID:200901039107738667
Update date: Dec. 18, 2024
Nakazawa Kenichi
ナカザワ ケンイチ | Nakazawa Kenichi
Contact this researcher
You can send email directly to the researcher.
Affiliation and department:
National Institute of Health Sciences Division of Pharmacology
About National Institute of Health Sciences Division of Pharmacology
Search "National Institute of Health Sciences Division of Pharmacology"
Detailed information
Research field (2):
Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (7):
イオン・チャネル
, ATP
, 薬理学
, Structure-function Relationship
, Ion Channel
, Purinoceptor
, ATP
Research theme for competitive and other funds (2):
細胞分子薬理学
Structure-function relationship of ATP receptor
MISC (11):
A highly conserved tryptophane residue indispensable for cloned rat neuronal P2X receptor activation. Neurosci. Lett. 2002. 324, 141-144
Ken Nakazawa, Yasuo Ohno, Kazuhide Inoue. An aspartic acid residue near the second transmembrane segment of ATP receptor/channel regulates agonist sensitivity. Biochemical and Biophysical Research Communications. 1998. 244. 2. 599-603
ATP受容体の構造と機能. 生体の科学 52:152-157 (2001)
ATP受容体チャネル:構造-機能相関探求への展望を中心に. ファルマシア 33:862-866 (1999)
Zinc potentiation of neurotransmission and inhibition of background cationic corductance in rat cultured hippocampal neurons. J. Physiology Vol.484, pp.447-462, 1995
more...
Education (3):
- 1987 The University of Tokyo
- 1982 The University of Tokyo Faculty of Pharmaceutical Sciences Department of Pharmacy
The University of Tokyo
Professional career (1):
Ph. D.
Work history (4):
1992 - :国立医薬品食品衛生研究所主任研究官
1992 - : Chief Research Officer of National Institute of Health Sciences
1987 - :国立医薬品食品衛生研究所研究官
1987 - : Research Officer of National Institute of Health Sciences
Committee career (1):
日本薬理学会 評議員
Association Membership(s) (4):
日本薬理学会
, 日本薬学会
, The Pharmaceutical Society of Japan
, Japanese Pharmacological Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM